Literature DB >> 19617947

Gabapentin and tiagabine for social anxiety: a randomized, double-blind, crossover study of 8 adults.

Maria R Urbano, David R Spiegel, Nena Laguerta, Catherine J Shrader, Daniel F Rowe, Liana F Hategan.   

Abstract

Entities:  

Year:  2009        PMID： 19617947      PMCID： PMC2708011          DOI： 10.4088/pcc.08l00641

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  9 in total

1.  Tiagabine for the treatment of anxiety.

Authors:  Daniel Crane
Journal:  Depress Anxiety       Date:  2003       Impact factor: 6.505

2.  Social phobia.

Authors:  M R Liebowitz
Journal:  Mod Probl Pharmacopsychiatry       Date:  1987

3.  Placebo-controlled study of gabapentin treatment of panic disorder.

Authors:  A C Pande; M H Pollack; J Crockatt; M Greiner; G Chouinard; R B Lydiard; C B Taylor; S R Dager; T Shiovitz
Journal:  J Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.153

4.  Examination of the known-groups validity of the Liebowitz Social Anxiety Scale.

Authors:  Richard G Heimberg; Robert M Holaway
Journal:  Depress Anxiety       Date:  2007       Impact factor: 6.505

Review 5.  Pharmacotherapy of social anxiety disorder: what does the evidence tell us?

Authors:  Jonathan R T Davidson
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 6.  Etiology and neurobiology of social anxiety disorder.

Authors:  Sanjay J Mathew; Stephanie Ho
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 7.  Social anxiety disorder clinical course and outcome: review of Harvard/Brown Anxiety Research Project (HARP) findings.

Authors:  Martin B Keller
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

8.  Tiagabine for the treatment of generalized anxiety disorder: a randomized, open-label, clinical trial with paroxetine as a positive control.

Authors:  Murray Rosenthal
Journal:  J Clin Psychiatry       Date:  2003-10       Impact factor: 4.384

Review 9.  Cellular and molecular action of the putative GABA-mimetic, gabapentin.

Authors:  Y P Maneuf; M I Gonzalez; K S Sutton; F Z Chung; R D Pinnock; K Lee
Journal:  Cell Mol Life Sci       Date:  2003-04       Impact factor: 9.261
  9 in total
  3 in total

1.  A Pharmacologic Algorithm for Youth Who Are at High Risk for Bipolar Disorder.

Authors:  Christopher D Schneck; Kiki D Chang; Manpreet K Singh; Melissa P DelBello; David J Miklowitz
Journal:  J Child Adolesc Psychopharmacol       Date:  2017-07-21       Impact factor: 2.576

Review 2.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

Review 3.  Pharmacotherapy for anxiety disorders in children and adolescents.

Authors:  Ian Kodish; Carol Rockhill; Chris Varley
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.